PTCT - PTC Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
67.0 3.03 (4.52%) --- --- 1.24 (1.8%) 0.0 (0.0%) 2.74 (4.16%) 1.28 (1.86%) 1.28 (1.86%)

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.83
Diluted EPS:
-0.83
Basic P/E:
-84.3735
Diluted P/E:
-84.3735
RSI(14) 1m:
100.0
VWAP:
70.03
RVol:
1.0177

Events

Period Kind Movement Occurred At

Related News